高蛋白饮食和与代谢功能障碍相关的脂肪性肝病:肝脏健康的双刃剑
Hong-Yuan Yin1, Qian-Hui You2, Wei-Jie Zhang3
1Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
World journal of gastroenterology
|February 16, 2026
概括
高蛋白饮食 (HPD) 对代谢功能障碍相关的脂肪性肝病 (MASLD) 产生混合影响. 植物性蛋白质提供了好处,这表明HPD对MASLD管理的个性化方法.
科学领域:
- 肝病学和营养科学 肝病学和营养科学
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD) 是一种广泛的慢性肝病,与代谢障碍相关.
- 高蛋白饮食 (HPD) 正在越来越多地研究代谢健康,但它们在MASLD中的作用仍在争论中.
研究的目的:
- 系统地审查HPD对MASLD的影响.
- 检查HPD在MASLD中的肝脏代谢,炎症和肠道微生物群上的机制.
- 评估HPD对MASLD的临床疗效.
主要方法:
- 对流行病学研究,临床试验和基础研究进行系统审查.
- 分析涉及肝脏代谢,炎症反应和肠道微生物群的机制.
- 临床疗效和蛋白质来源影响的评估.
主要成果:
- HPD对MASLD产生双重影响,受蛋白质来源和摄入水平的影响.
- 植物性蛋白质在MASLD患者中显示出代谢优势.
- 特定的蛋白质来源和消费模式对于MASLD的结果至关重要.
结论:
- 患有MASLD的患者应优先考虑植物性蛋白质和适度的动物蛋白质摄入量.
- 未来的研究应该集中在HPD机制和个性化的营养策略上.
- 整合多omics数据可以为MASLD预防和治疗提供精确的饮食算法.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Overview of Lipid Metabolism
5.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
257
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
257
Overview of Protein Metabolism
4.1K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.1K
Liver Physiology
3.9K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234


